Are you Dr. Duke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-543-6420Fax+1 608-890-7127
Summary
- Dr. Elizabeth Duke, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Wisconsin. She is affiliated with Fred Hutch Cancer Center, UW Medicine/Harborview Medical Center, and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonFellowship, Infectious Disease, 2017
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2010 - 2013
Marshall University Joan C. Edwards School of MedicineClass of 2010
Certifications & Licensure
WA State Medical License 2014 - 2025
WI State Medical License 2012 - 2015
Publications & Presentations
PubMed
- CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation.Danniel Zamora, Hu Xie, Alicja Sadowska-Klasa, Eleftheria Kampouri, Melinda A Biernacki
Blood Advances. 2024-09-10 - 3 citationsDynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective obs...Maria Salgado, Cristina Gálvez, Monique Nijhuis, Mi Kwon, E Fabian Cardozo-Ojeda
The Lancet. HIV. 2024-06-01 - 7 citationsStochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation.Stefan Radtke, Mark Enstrom, Dnyanada Pande, Elizabeth R Duke, E Fabian Cardozo-Ojeda
Blood. 2023-07-06
Press Mentions
What You Need to Know About Access to COVID Antiviral Drugs and Therapeutics in King County and WAJune 13th, 2022- Can These Drugs Stop a COVID Infection in Its Tracks? Seattle Researchers Are on the Forefront of New TreatmentsJune 13th, 2022
- Merck Says It Has the First Antiviral Pill Found to Be Effective Against CovidOctober 1st, 2021
